A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys

Vaccine

Volumn 18, Issue 27, 2000, Pages 3166-3173

  Kochel, T J ^a   Raviprakash, K ^a,b   Hayes, C G ^a   Watts, D M ^c   Russell, K L ^c   Gozalo, A S ^c   Phillips, I A ^a   Ewing, D F ^a,b   Murphy, G S ^a,b   Porter, K R ^c  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^c NONE

Author keywords

Aotus nancymae; Dengue virus; DNA vaccine

Indexed keywords

DNA VACCINE; NEUTRALIZING ANTIBODY; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DENGUE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIREMIA; VIRUS INFECTION;

EID: 0034662483     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00105-5     Document Type: Article

References (38)

1. Chambers T.J., Hahn C.S., Galler R., Rice C.M. Flavivirus genome organization, expression and replication. A. Rev. Microbiol. 44:1990;649-688.
2. Halstead S.B. Pathogenesis of dengue: challenges to molecular biology. Science. 239:(4839):1988;476-481.
3. Gubler D.J., Clark G.G. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg. Infect. Dis. 1:(2):1995;55-57.
4. Barrett A.D. Japanese encephalitis and dengue vaccines. Biologicals. 25:(1):1997;27-34.
5. Barrett A.D. Yellow fever vaccines. Biologicals. 25:(1):1997;17-25.
6. Schlesinger R.W. Dengue Viruses. Virol. Monogr. 16:1977;1-132.
7. Edelman R., Tacket C.O., Wasserman S.S., Vaughn D.W., Eckels K.H., Dubois D.R., Summers P.L., Hoke C.H. A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans. J. Infect. Dis. 170:(6):1994;1448-1455.
8. McKee K.T. Jr, Bancroft W.H., Eckels K.H., Redfield R.R., Summers P.L., Russell P.K. Lack of attenuation of a candidate dengue 1 vaccine (45AZ5) in human volunteers. Am. J. Trop. Med. Hyg. 36:(2):1987;435-442.
9. Eckels K.H., Dubois D.R., Summers P.L., Schlesinger J.J., Shelly M., Cohen S., Zhang Y.M., Lai C.J., Kurane I., Rothman A., et al. Immunization of monkeys with baculovirus-dengue type-4 recombinants containing envelope and nonstructural proteins: evidence of priming and partial protection. Am. J. Trop. Med. Hyg. 50:(4):1994;472-478.
10. Deubel V., Kinney R.M., Esposito J.J., Cropp C.B., Vorndam A.V., Monath T.P., Trent D.W. Dengue 2 virus envelope protein expressed by a recombinant vaccinia virus fails to protect monkeys against dengue. J. Gen. Virol. 69:(Pt 8):1988;1921-1929.
11. Porter K.R., Kochel T.J., Wu S.J., Raviprakash K., Phillips I., Hayes C.G. Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses. Arch. Virol. 143:(5):1998;997-1003.
12. Colombage G., Hall R., Pavy M., Lobigs M. DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. Virology. 250:(1):1998;151-163.
13. Phillpotts R.J., Venugopal K., Brooks T. Immunisation with DNA polynucleotides protects mice against lethal challenge with St Louis encephalitis virus. Arch. Virol. 141:(3-4):1996;743-749.
14. Schmaljohn C., Vanderzanden L., Bray M., Custer D., Meyer B., Li D., Rossi C., Fuller D., Fuller J., Haynes J., Huggins J. Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge. J. Virol. 71:(12):1997;9563-9569.
15. Konishi E., Yamaoka M., Khin Sane W., Kurane I., Mason P.W. Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes. J. Virol. 72:(6):1998;4925-4930.
16. Allison S.L., Stadler K., Mandel C.W., Kunz C., Heinz F.X. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluable and particulate form. J. Virol. 69:1995;5816-5820.
17. Rey F.A., Heinz F.X., Mandel C., Kunz C., Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature. 375:1995;291-298.
18. Raviprakash K, Kochel T, Porter K, Ewing D, Simmons M, Phillips I, Murphy G, Hayes C, Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein, Vaccine 2000; (in press).
19. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning a laboratory manual. 1989;Cold Spring Harbor Laboratory Press.
20. Ansari M., Shope R., Malik S. Evaluation of vero cell lysate antigen for the ELISA of flaviviruses. J. Clin. Lab. 7:1993;230-237.
21. Russell P.K., Nisalak A. Dengue virus identification by the plaque reduction neutralization test. J. Immunol. 99:(2):1967;291-296.
22. Nash D.R., Halstead S.B., Stenhouse A.C., McCue C. Nonspecific factors in monkey tissues and serum causing inhibition of plaque formation and hemagglutination. Infection and Immunity. 3:(2):1971;193-199.
23. Henchal E.A., Gentry M.K., McCown J.M., Brandt W.E. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am. J. Trop. Med. Hyg. 31:(4):1982;830-836.
24. Gramzinski R.A., Millan C.L., Obaldia N., Hoffman S.L., Davis H.L. Immune response to a hepatitis B DNA vaccine in Aotus monkeys: a comparison of vaccine formulation, route, and method of administration. Mol. Med. 4:(2):1998;109-118.
25. Gramzinski R.A., Maris D.C., Doolan D., Charoenvit Y., Obaldia N., Rossan R., Sedegah M., Wang R., Hobart P., Margalith M., Hoffman S. Malaria DNA vaccines in Aotus monkeys. Vaccine. 15:(8):1997;913-915.
26. Halstead S., Casals J., Shotwell H., Palumbo N. Studies on the immunization of monkeys against dengue. 1. Protection derived from single and sequential virus infections. Am. J. Trop. Med. Hyg. 22:1973;3365-3374.
27. Hartmann G., Weiner G.J., Krieg A.M. CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. USA. 96:1999;9305-9310.
28. Raz E., Carson D.A., Parker S.E., Parr T.B., Abai A.M., Aichinger G., Gromkowski S.H., Singh M., Lew D., Yankauckas M.A., et al. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA. 91:(20):1994;9519-9523.
29. Klinman D.M., Sechler J.M., Conover J., Gu M., Rosenberg A.S. Contribution of cells at the site of DNA vaccination to the generation of antigen-specific immunity and memory. J. Immunol. 160:(5):1998;2388-2392.
30. Akbari O., Panjwani N., Garcia S., Tascon R., Lowrie D., Stockinger B. DNA vaccination: transfection and activation of dendritic cells as key events for immunity. J. Exp. Med. 189:(1):1999;169-178.
31. Scott R.M., Nisalak A., Eckels K.H., Tingpalapong M., Harrison V.R., Gould D.J., Chapple F.E., Russell P.K. Dengue-2 vaccine: viremia and immune responses in rhesus monkeys. Infect. Immun. 27:(1):1980;181-186.
32. Whitehead R.H., Chaicumpa V., Olson L., Russell P. Sequential dengue virus infections in the white-handed gibbon (Hylobates lar). Am. J. Trop. Med. Hyg. 19:(1):1970;94-102.
33. Harrison V.R., Eckels K.H., Sagartz J.W., Russell P.K. Virulence and immunogenicity of a temperature-sensitive dengue-2 virus in lower primates. Infection and Immunity. 18:(1):1977;151-156.
34. Bray M., Men R., Lai C.J. Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge. J. Virol. 70:(6):1996;4162-4166.
35. Scherer W.F., Breakenridge F.A., Dickerman R.W. Cross-protection studies and search for subclinical disease in new world monkeys infected sequentially with different immunnologic types of dengue viruses. Am. J. Epid. 95:(1):1972;67-79.
36. Konishi E., Yamaoka M., Khin Sane W., Kurane I., Takada K., Mason P.W. The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes. J. Virol. 73:(7):1999;5527-5534.
37. Lee H.W., Scherer W.F. The anamnestic antibody response to Japanese encephalitis virus in monkeys and its implications concerning naturally acquired immunity in man. J. Immunol. 86:1961;151-164.
38. Mason R.A., Tauraso N.M., Spertzel R.O., Ginn R.K. Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine. Appl. Microbiol. 25:(4):1973;538-544.